日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Morphological and Phenological Diversity of Pod Corn (Zea mays Var. Tunicata) from Mexico and Its Functional Traits Under Contrasting Environments

墨西哥荚果玉米(Zea mays var. Tunicata)的形态和物候多样性及其在不同环境下的功能性状

Romero-Cortes, Teresa; Vázquez Mejía, Raymundo Lucio; Aparicio-Burgos, José Esteban; Peralta-Gil, Martin; Armendáriz-Ontiveros, María Magdalena; Morales-Ovando, Mario A; Cuervo-Parra, Jaime Alioscha

Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer

DUO-E 研究结果的简明语言总结:度伐利尤单抗联合或不联合奥拉帕尼治疗晚期子宫内膜癌患者

Westin, Shannon N; Moore, Kathleen; Chon, Hye Sook; Lee, Jung-Yun; Thomes Pepin, Jessica; Sundborg, Michael; Shai, Ayelet; de la Garza, Joseph; Nishio, Shin; Gold, Michael A; Wang, Ke; McIntyre, Kristi; Tillmanns, Todd D; Blank, Stephanie V; Liu, Ji-Hong; McCollum, Michael; Contreras Mejia, Fernando; Nishikawa, Tadaaki; Pennington, Kathryn; Novak, Zoltan; De Melou, Andreia Cristina; Sehouli, Jalid; Klasa-Mazurkiewicz, Dagmara; Papadimitriou, Christos; Gil-Martin, Marta; Brasiuniene, Birute; Donnelly, Conor; Liu, Xiaochun; Nieuwenhuysen, Els Van

Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial

Tucatinib 和 trastuzumab 治疗 HER2 突变转移性乳腺癌:一项 II 期篮式试验

Okines, Alicia F C; Curigliano, Giuseppe; Mizuno, Nobumasa; Oh, Do-Youn; Rorive, Andree; Soliman, Hatem; Takahashi, Shunji; Bekaii-Saab, Tanios; Burkard, Mark E; Chung, Ki Y; Debruyne, Philip R; Fox, Jenny R; Gambardella, Valentina; Gil-Martin, Marta; Hamilton, Erika P; Monk, Bradley J; Nakamura, Yoshiaki; Nguyen, Danny; O'Malley, David M; Olawaiye, Alexander B; Pothuri, Bhavana; Reck, Martin; Sudo, Kazuki; Sunakawa, Yu; Van Marcke, Cedric; Yu, Evan Y; Ramos, Jorge; Tan, Sherry; Bieda, Mark; Stinchcombe, Thomas E; Pohlmann, Paula R

Epigenetic signatures, age acceleration, and injury risk in elite female and male soccer players

精英男女足球运动员的表观遗传特征、衰老加速和受伤风险

Pérez, Raúl F; Lecumberri-Arteta, Jon; Kulis, Marta; Botta-Orfila, Teresa; Rodríguez-Vilarrupla, Aina; Yanguas, Xavier; Ferrer, Eva; Rodas, Gil; Martin-Subero, Jose I

SEOM-GEICO clinical guidelines on endometrial cancer (2025)

SEOM-GEICO子宫内膜癌临床指南(2025年)

Ramírez, Sara Pérez; Fidalgo, Alejandro Pérez; Ginesta, María Pilar Barretina; De Juan Ferré, Ana; Madrid, Lorena Fariñas; Martínez, Alejandro Gallego; Montosa, Fernando Gálvez; Madariaga, Ainhoa; Gómez, Teresa Martin; Gil-Martin, Marta

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Durvalumab联合卡铂/紫杉醇治疗后序贯Durvalumab维持治疗(可联合或不联合奥拉帕尼)作为晚期子宫内膜癌的一线治疗:III期DUO-E试验

Westin, Shannon N; Moore, Kathleen; Chon, Hye Sook; Lee, Jung-Yun; Thomes Pepin, Jessica; Sundborg, Michael; Shai, Ayelet; de la Garza, Joseph; Nishio, Shin; Gold, Michael A; Wang, Ke; McIntyre, Kristi; Tillmanns, Todd D; Blank, Stephanie V; Liu, Ji-Hong; McCollum, Michael; Contreras Mejia, Fernando; Nishikawa, Tadaaki; Pennington, Kathryn; Novak, Zoltan; De Melo, Andreia Cristina; Sehouli, Jalid; Klasa-Mazurkiewicz, Dagmara; Papadimitriou, Christos; Gil-Martin, Marta; Brasiuniene, Birute; Donnelly, Conor; Del Rosario, Paula Michelle; Liu, Xiaochun; Van Nieuwenhuysen, Els

Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer

Bintrafusp Alfa 一线治疗局部晚期或持续性/复发性/转移性宫颈癌患者的 I 期试验

Oaknin, Ana; Ghamande, Sharad A; Kasamatsu, Yuka; Gil-Martin, Marta; Grau-Bejar, Juan Francisco; Garcia-Duran, Carmen; Sato, Masashi; Siddiqui, Abdul; Chaudhary, Surendra Pal; Vugmeyster, Yulia; Hasegawa, Kosei

Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)

晚期卵巢癌新辅助化疗联合或不联合贝伐单抗治疗后肿瘤微环境变化的分析(GEICO-89T/MINOVA 研究)

Beatriz Tavira ,Teresa Iscar ,Luis Manso ,Ana Santaballa ,Marta Gil-Martin ,Yolanda García García ,Margarita Romeo ,Maria Iglesias ,Ana de Juan Ferré ,María Pilar Barretina-Ginesta ,Aranzazu Manzano ,Lydia Gaba ,María Jesús Rubio ,Carlos E de Andrea ,Antonio González-Martín

ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer

ENDOLUNG试验。一项针对晚期/复发性子宫内膜癌患者的1/2期研究,旨在评估Akt/mTOR抑制剂和自噬诱导剂Ibrilatazar(ABTL0812)联合紫杉醇/卡铂的疗效。

Leary, Alexandra; Estévez-García, Purificación; Sabatier, Renaud; Ray-Coquard, Isabelle; Romeo, Margarita; Barretina-Ginesta, Pilar; Gil-Martin, Marta; Garralda, Elena; Bosch-Barrera, Joaquim; Morán, Teresa; Martin-Martorell, Paloma; Nadal, Ernest; Gascón, Pere; Rodon, Jordi; Lizcano, Jose M; Muñoz-Guardiola, Pau; Fierro-Durán, Gemma; Pedrós-Gámez, Oriol; Pérez-Montoyo, Héctor; Yeste-Velasco, Marc; Cortal, Marc; Pérez-Campos, Antonio; Alfon, Jose; Domenech, Carles; Pérez-Fidalgo, Alejandro; Oaknin, Ana

Correction: ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer : Alexandra Leary

更正:ENDOLUNG试验。一项评估Akt/mTOR抑制剂和自噬诱导剂Ibrilatazar(ABTL0812)联合紫杉醇/卡铂治疗晚期/复发性子宫内膜癌患者的I/II期临床研究:Alexandra Leary

Leary, Alexandra; Estévez-García, Purificación; Sabatier, Renaud; Ray-Coquard, Isabelle; Romeo, Margarita; Barretina-Ginesta, Pilar; Gil-Martin, Marta; Garralda, Elena; Bosch-Barrera, Joaquim; Morán, Teresa; Martin-Martorell, Paloma; Nadal, Ernest; Gascón, Pere; Rodon, Jordi; Lizcano, Jose M; Muñoz-Guardiola, Pau; Fierro-Durán, Gemma; Pedrós-Gámez, Oriol; Pérez-Montoyo, Héctor; Yeste-Velasco, Marc; Cortal, Marc; Pérez-Campos, Antonio; Alfon, Jose; Domenech, Carles; Pérez-Fidalgo, Alejandro; Oaknin, Ana